Search by Drug Name or NDC

    NDC 50090-3491-00 Tresiba 200 U/mL Details

    Tresiba 200 U/mL

    Tresiba is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is INSULIN DEGLUDEC.

    Product Information

    NDC 50090-3491
    Product ID 50090-3491_ee96b54f-5204-4b1b-8e9c-593f56045b66
    Associated GPIs 2710400700D220
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Tresiba
    Proprietary Name Suffix n/a
    Non-Proprietary Name insulin degludec
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 200
    Active Ingredient Units U/mL
    Substance Name INSULIN DEGLUDEC
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class Insulin Analog [EPC], Insulin [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA203314
    Listing Certified Through 2024-12-31

    Package

    NDC 50090-3491-00 (50090349100)

    NDC Package Code 50090-3491-0
    Billing NDC 50090349100
    Package 3 SYRINGE, PLASTIC in 1 CARTON (50090-3491-0) / 3 mL in 1 SYRINGE, PLASTIC
    Marketing Start Date 2018-06-20
    NDC Exclude Flag N
    Pricing Information N/A